273 related articles for article (PubMed ID: 1329625)
1. Pharmacokinetic studies of CP-74,667, a new quinolone, in laboratory animals.
Girard D; Gootz TD; McGuirk PR
Antimicrob Agents Chemother; 1992 Aug; 36(8):1671-6. PubMed ID: 1329625
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys.
Teng R; Girard D; Gootz TD; Foulds G; Liston TE
Antimicrob Agents Chemother; 1996 Mar; 40(3):561-6. PubMed ID: 8851571
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of a novel quinolone, AT-4140, in animals.
Nakamura S; Kurobe N; Ohue T; Hashimoto M; Shimizu M
Antimicrob Agents Chemother; 1990 Jan; 34(1):89-93. PubMed ID: 2327763
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of a new quinolone, AM-833, in mice, rats, rabbits, dogs, and monkeys.
Kusajima H; Ishikawa N; Machida M; Uchida H; Irikura T
Antimicrob Agents Chemother; 1986 Aug; 30(2):304-9. PubMed ID: 3094441
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, tissue distribution, and excretion of sitafloxacin, a new fluoroquinolone antibiotic, in rats, dogs, and monkeys.
Tachibana M; Tanaka M; Mitsugi K; Jin Y; Takaichi M; Okazaki O
Arzneimittelforschung; 2004; 54(12):898-905. PubMed ID: 15646375
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
Mukai H; Sugimoto T; Ago M; Morino A
Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
[TBL] [Abstract][Full Text] [Related]
8. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the new fluoroquinolone balofloxacin in mice, rats, and dogs.
Nakagawa T; Ishigai M; Kato M; Hayakawa N; Kinoshita H; Okutomi T; Ohkubo K; Okazaki A
Arzneimittelforschung; 1995 Jun; 45(6):719-22. PubMed ID: 7646579
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers.
Nakashima M; Uematsu T; Kosuge K; Umemura K; Hakusui H; Tanaka M
Antimicrob Agents Chemother; 1995 Jan; 39(1):170-4. PubMed ID: 7695301
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys.
Kita Y; Fugono T; Imada A
Antimicrob Agents Chemother; 1986 Jan; 29(1):127-34. PubMed ID: 3729325
[TBL] [Abstract][Full Text] [Related]
12. [Absorption, distribution, metabolism and excretion of T-3761, a new quinolone derivative, in experimental animals].
Minami S; Takahata M; Hayashi T; Kumano K; Ikeda Y; Noumi T; Takagi S; Oogake N; Tsuneda R; Maehana J
Jpn J Antibiot; 1995 May; 48(5):626-42. PubMed ID: 7637197
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic determination of 6,8-difluoro-1-(2-fluoroethyl)-1,4- dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid and its metabolites in laboratory animals.
Kusajima H; Ooie T; Kawahara F; Uchida H
J Chromatogr; 1986 Aug; 381(1):137-48. PubMed ID: 3095363
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tissue distribution of rifametane, a new 3-azinomethyl-rifamycin derivative, in several animal species.
Bruzzese T; Rimaroli C; Bonabello A; Mozzi G; Ajay S; Cooverj ND
Arzneimittelforschung; 2000 Jan; 50(1):60-71. PubMed ID: 10683718
[TBL] [Abstract][Full Text] [Related]
15. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
Radulovic LL; Türck D; von Hodenberg A; Vollmer KO; McNally WP; DeHart PD; Hanson BJ; Bockbrader HN; Chang T
Drug Metab Dispos; 1995 Apr; 23(4):441-8. PubMed ID: 7600909
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of SCH 56592, a new azole broad-spectrum antifungal agent, in mice, rats, rabbits, dogs, and cynomolgus monkeys.
Nomeir AA; Kumari P; Hilbert MJ; Gupta S; Loebenberg D; Cacciapuoti A; Hare R; Miller GH; Lin CC; Cayen MN
Antimicrob Agents Chemother; 2000 Mar; 44(3):727-31. PubMed ID: 10681346
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of prulifloxacin. 3rd communication: metabolism in rats, dogs and monkeys.
Okuyama Y; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):293-8. PubMed ID: 9105548
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
Nakamura S; Kurobe N; Kashimoto S; Ohue T; Takase Y; Shimizu M
Antimicrob Agents Chemother; 1983 Jul; 24(1):54-60. PubMed ID: 6226241
[TBL] [Abstract][Full Text] [Related]
20. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans.
Nakashima M; Uematsu T; Kosuge K; Kusajima H; Ooie T; Masuda Y; Ishida R; Uchida H
Antimicrob Agents Chemother; 1995 Dec; 39(12):2635-40. PubMed ID: 8592993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
